The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Speak Out Rheum: The First Days of Rheumatology

Speak Out Rheum: The First Days of Rheumatology

July 1, 2013 • By Charles M. Plotz, MD, MedScD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
The First Days of Rheumatology

You Might Also Like
  • Speak Out Rheum: Fifty Years of APLAR
  • Speak Out Rheum: ACR/EULAR Exchange Program Expands Rheumatology Networks
  • Speak Out Rheum: Under the Radar
Explore This Issue
July 2013

It is difficult to realize that in 1948, when I was finishing an internal medicine residency and service in the Army Air Corps and was ready for advanced training, there was no such field as rheumatology—even the word did not exist. That changed in 1949 when, at a monumental meeting of the American Rheumatism Association at the Waldorf-Astoria Hotel in New York (there were fewer than 400 members), Philip Hench delivered his seminal paper on the effect of Compound E (cortisone) on rheumatoid arthritis. I was there and joined the entire audience in a standing ovation. It was one of medicine’s turning points, and I was hooked. “Rheumatology” was born, and I became the first ever fellow in rheumatology at the Columbia-Presbyterian Medical Center in New York.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Robert Loeb, chairman of medicine, although somewhat skeptical, assigned a bright young member of his department to be my mentor, and I lucked out. He was Charlie Ragan, who became one of the pillars in our field. By the time I had finished training with him, I had written several papers, including my first Citation Classic—“The Natural History of Cushing’s Syndrome,”—which warned about the newly discovered hazards of steroid use.

There were a few other pockets of arthritis investigation in the United States—Walter Bauer at Harvard, Dick Freyberg at Michigan, Joe Hollander in Philadelphia, Charley Smyth in Denver, Currier McEwen at NYU (the spawning ground for Joe Bunim and Morris Ziff), and Hench at the Mayo Clinic. Some clinicians, including Ralph Boots and Russell Cecil, began to specialize in the management of arthritis and rheumatism. Boots was a big promoter of the use of gold, while Cecil favored the use of Scotch whiskey. Alexander Gutman emerged as an authority on gout, and when he left Columbia in 1951 to become the chairman of medicine at Mount Sinai, he asked me to come along.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Expanding Rheumatology in the Clinic and the Lab

My first task at Mount Sinai was to establish an Arthritis Clinic, but there were no trained rheumatologists to staff it. Fortunately, in New York, there were a number of very smart and able clinicians, several of whom I was able to recruit. These included Adolph Weissman, father of Gerald Weissman, who achieved great fame in our field; Joseph Pincus, whose son, Ted, is still a leader in our field; Maurice Wolf; and Selvan Davison. A later addition was the formidable Harry Spiera, who eventually succeeded me as division head when I chose to return to Brooklyn as chief at the newly established State University of New York (SUNY) Downstate.

Pages: 1 2 3 4 | Single Page

Filed Under: Professional Topics Tagged With: History, rheumatologyIssue: July 2013

You Might Also Like:
  • Speak Out Rheum: Fifty Years of APLAR
  • Speak Out Rheum: ACR/EULAR Exchange Program Expands Rheumatology Networks
  • Speak Out Rheum: Under the Radar
  • Speak Out Rheum: How the U.K. and U.S. Healthcare Models Stack Up

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)